Skip to content
DataLookout
Menu

NCT05250908

INTIBIA Pivotal Study

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 17 versions: 15 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 34 words
    • Study completion pushed from Jun 27, 2026 to Jun 2029
    • Site details revised at 2 of 22 sites
    • Study description expanded, about 3 words
  2. Minor Primary completion date: Jun 27, 2025 to May 12, 2025v16
  3. Notable Enrollment target: 108 to 208
    • Primary completion date: May 5, 2025 to Jun 27, 2025
    • Study completion date: May 5, 2026 to Jun 27, 2026
    v13
  4. Minor Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 225 to confirmed 108
    • Study sites: 24 to 22
    v12
  5. Notable Primary completion date: Mar 7, 2024 to May 5, 2025
    • Study completion date: Mar 7, 2025 to May 5, 2026
    v11
Show 9 earlier versionsHide 9 earlier versions
  1. Minor Site contacts updated at 1 of 24 sitesv10
  2. Notable Eligibility criteria expanded, about 9 words
    • Study sites: 19 to 24
    v9
  3. Minor Study sites: 18 to 19v8
  4. Minor Study sites: 15 to 18v7
  5. Minor Study sites: 11 to 15v6
  6. Minor Study sites: 6 to 11v5
  7. Minor Study sites: 2 to 6v4
  8. Minor Study sites: 1 to 2
    • Primary completion date: Mar 1, 2024 to Mar 7, 2024
    • Study completion date: Mar 1, 2025 to Mar 7, 2025
    • Start date changed from estimate of Mar 1, 2022 to Mar 7, 2022
    v3
  9. Minor Secondary endpoints: details revised at 1 of 2 entriesv2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Response Rate
Timeframe: 3 Months

Secondary (2)

Urgency Score
Daily Voids

Arms and interventions

INTIBIA TherapeuticExperimental

Implanted with INTIBIA device and programmed to therapeutic stimulation for the duration of the study.

INTIBIA Non-TherapeuticExperimental

Implanted with INTIBIA device and programmed to non-therapeutic stimulation for the first 3 months, then to therapeutic stimulation for the duration of the study.

Devices: INTIBIA Therapeutic, INTIBIA Non-Therapeutic

Sites

22 sites in 2 countries

United States 20, Netherlands 2